| Application no. and date | 01940687.5 (espacenet) (Federated) (European Patent Register), 20010605 | | Patent/reg. no. and date | DK/EP 1299102, 20060419 | | Publication date | 20030409 | | Priority no. and date | FR 0007162, 20000605 | | EP pub. no. and date |
EP 1299102 20030409 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR,
INSTITUT NATIONAL DE LA SANTE ET
DE LA RECHERCHE MEDICALE (INSERM), 101, rue de Tolbiac
75654 Paris Cédex 13, FR | | Applicant ref. no. | AVENT ST 00017 | | Inventor | STUTZMANN, Jean-Marie, 9 Rue de l'Arche
F-94440 Villecresnes, FR,
AUBOURG, Patrick, 96 rue Thiers
F-92100 BOULOGNE-BILLANCOURT, FR,
DIB, Michel, 30 rue Clisson
F-75013 Paris, FR | | Representative | | | Opponent | | | IPC Class | A61K 31/425 (2006.01) , A61P 3/00 (2006.01) | | Title | Anvendelse af riluzol eller salte deraf til forebyggelse og behandling af adrenoleukodystrofi | | Int. application no. | FR2001001729 | | Int. publication no. | WO2001093802 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
